Portolan Capital Management - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 71 filers reported holding RECRO PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Portolan Capital Management ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2021$332,000
-92.4%
161,253
-91.5%
0.02%
-92.4%
Q2 2021$4,380,000
-19.8%
1,896,085
-3.1%
0.32%
-26.6%
Q1 2021$5,461,000
+48.2%
1,957,283
+51.3%
0.43%
+28.1%
Q4 2020$3,686,000
+666.3%
1,293,376
+464.3%
0.34%
+520.4%
Q3 2020$481,000
-42.4%
229,210
+24.9%
0.05%
-43.2%
Q2 2020$835,000183,5540.10%
Other shareholders
RECRO PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders